American Society of Hematology Conference Features Exciting MPN Updates Including MPNRF Funded Research Normally the annual meeting of the American Society of Hematology (commonly referred… Read More »ASH CONFERENCE FEATURES EXCITING MPN UPDATES INCLUDING MPNRF FUNDED RESEARCH
March 8th is recognized as International Women’s Day, a day to recognize the contribution of women to society, globally. The MPN Research Foundation has long… Read More »INTERNATIONAL WOMEN’S DAY: THANK YOU TO OUR MPN RESEARCHERS!
April 12, 2019 After completing a number of clinical trials, The MPN community was disappointed when a promising compound in development for myelofibrosis, momelotinib, was… Read More »PROMISING MF TREATMENT, MOMELOTINIB, IN DEVELOPMENT ONCE MORE
The MPN Research Foundation has invested more in Interferon research in the past few years through our MPN Interferon Initiative, a global collaboration among researchers… Read More »MPNRF’S EXECUTIVE DIRECTOR DISCUSSES THE INTERFERON INITIATIVE
You may have heard that MPNRF, along with fellow MPN advocates, is holding an externally-led Patient Focused Drug Development meeting with the FDA this September. If you are… Read More »LET THE FDA KNOW ABOUT YOUR EXPERIENCE LIVING WITH PV, ET OR MF!
Identifying Myeloproliferative Neoplasms (MPNs) can be a challenge. Many symptoms are general and correspond with a variety of other conditions that are not necessarily specific… Read More »HOW TO IDENTIFY MYELOPROLIFERATIVE NEOPLASMS